Antiviral patents: How prepared are we to combat novel viral diseases?

Webinar
April 20, 2020

Antiviral patents: How prepared are we to combat novel viral diseases?

With the novel coronavirus spreading both fear and illness across the world, it is a worthwhile exercise to look at the patent landscape of antiviral vaccines. By analyzing both the quality and quantity of the patent portfolios of the world's leading manufacturers and researchers, it is possible to evaluate the companies and research institutes that are at the forefront of finding vaccines and cures for potentially deadly viral diseases.

Join our webinar to learn more about:
* The entire technology field and key players in antiviral vaccine market
* Review of selected companies who have technologies related to coronavirus
* Portfolio landscaping of global pharma leaders in this technology field
* How PatentSight metrics evaluate the portfolio strength

If you are unable to attend the live webinar session, we will send you a link to the recording, which you can watch according to your schedule. Please make sure to register by filling out the form and clicking on submit. Only then can we send you the link by email, as soon as we have uploaded the recording.